These topics will be addressed by the company at this year's Pharmapack in Paris (5-6 February)
The new Robust RFID-Label from Schreiner MediPharm ensures
reliable end-to-end functionality of the RFID chip
'Connectivity' and 'Integrity of the Supply Chain' are two hot topics of the pharmaceutical industry to be addressed by Schreiner MediPharm at this year’s Pharmapack in Paris. On 5-6 February, in Hall 7.2 at Booth D46, the pharma label specialist will present a special product innovation: a Robust RFID-Label delivering reliable end-to-end functionality from production to final use. Two other innovative products to be showcased ensure the integrity of primary containers: Cap-Lock for sealing prefilled syringes and Flexi-Cap Prime that irreversibly indicates any tampering attempt on a vial.
Interaction between the user and the pharmaceutical manufacturer, and communication between the product and a medical device: Equipping pharmaceutical products and medical devices with RFID-Labels results in smart devices that help optimize processes and enhance ease and safety of use. Extreme robustness and perfect performance of the RFID-Labels throughout the various processing stages and across the entire supply chain are prerequisites for achieving these objectives. Particularly critical to ensuring robustness is the label's design.
The new Robust RFID-Label from Schreiner MediPharm consists of a label-integrated RFID tag that is secured by the label's special construction. Thus, potential damage to the RFID chip, for instance due to mechanical impact during the manufacturing and handling processes, can be avoided. This guarantees perfect end-to-end performance of the RFID chip from production to final use – especially on round containers with narrow radii. Schreiner MediPharm customizes the label’s design to suit the respective application and pharmaceutical manufacturing process. Thus, pharmaceutical manufacturers are provided with an effective and reliable solution supporting product and patient safety.
Ever since the EU Falsified Medicines Directive came into effect, tampering with secondary packaging of prescription medicines has been more difficult. However, legislation has not yet resolved the issue of ensuring the integrity of primary containers. With Cap-Lock and Flexi-Cap Prime, Schreiner MediPharm is presenting two security concepts that prevent undetected opening of a primary container and thus ensure its integrity: The Cap-Lock cap adapter seals prefilled luer-lock syringes and reliably indicates if a syringe has been opened before. The innovative Flexi-Cap Prime cap label makes any attempt of tampering with a vial irreversibly visible.
Schreiner MediPharm will also take part in the Pharmapack conference program and present the following topics together with its partners: